Regis Healthcare Limited Stock: price and insider trades · Australia

Every trade that managers of Regis Healthcare Limited disclose to ASX is tracked on this page. The company sits in the Health Care sector. In the past year (18 October 2025 to 18 October 2026), 10 filings came from 9 insiders.

Purchases and sales both appear in the filings: 5 purchases (5 insiders, €426k) and 1 sale (1 insider, €915k). The net balance comes to €488k on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The buyers include 5 senior executives. Biggest ticket of the year: €915k, sold by Linda Jane Mellors and made public on 7 May 2026 (0.079% of market cap).

Within a 30-day window, 3 purchases overlapped with buying by a second insider. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. The most recent open-market purchase was published on 14 September 2026, 56 days ago. Filings reach the ASX feed a median of 3 days after the trade. Until a filing is published, the market cannot know about the trade.

Compared with its exchange (1,605 companies, median 4 filings), a count of 10 filings is above the norm. Over the whole record (from 2026), the tally stands at 5 purchases and 1 sale.

For comparison within the same sector, see the insider buying recorded at Anixa Biosciences Inc and Vivos Inc. Every figure here comes from the filings published by ASX and describes the past, not future prices; it is not investment advice.